Is Ozempic better than Saxenda?

However, the most important difference between the two is, that Saxenda is licenced for use as weight loss medication in the UK and Ozempic is not. Unfortunately, there are a few unscrupulous websites and weight loss clinics, that are selling Ozempic, putting profit before safety.

webmedpharmacy.co.uk - Ozempic vs Saxenda - FREE next day UK delivery - Webmed Pharmacy

Will phentermine give me energy?

When you use a CNS stimulant like Phentermine, you can expect to feel more awake and alert. This is because amphetamines increase the levels of...

Last updated Oct 2, 2018

Can you get a tummy tuck at 220 pounds?

Whether you're looking for a large tummy tuck at 150 pounds, 220 pounds, or even 250 pounds, Dr. LaBarbera can help you attain the desired results....

Last updated Aug 6, 2021

Promotion

Posted

What is Ozempic?

Recently, the media have been promoting a product called Ozempic and have quoted many success stories from people who have achieved dramatic weight loss by using it. However, Ozempic is not licensed for weight loss and is actually licenced for use in the UK, to control type 2 diabetes.

Is there an alternative to Ozempic?

Yes, there is a very effective product called Saxenda, this is licenced in the UK for weight loss by the MHRA which is available now, to help make your weight loss journey much more successful.

From only £50 per pen

Saxenda dramatically reduces your appetite and combined with a healthy diet and lifestyle can help you to achieve your weight loss goal.

What is the main difference between Ozempic and Saxenda?

On reading the media articles it would appear, that the main difference between Saxenda and Ozempic, is that Saxenda is a daily injection and Ozempic is a weekly injection. However, the most important difference between the two is, that Saxenda is licenced for use as weight loss medication in the UK and Ozempic is not. Unfortunately, there are a few unscrupulous websites and weight loss clinics, that are selling Ozempic, putting profit before safety.

Is Ozempic safe and legal for weight loss?

Before a medicine can be widely used in the UK, it must first be granted a license. Licences are only granted if strict safety and quality standards are met. In the UK, licences are granted by the Medicines and Healthcare products Regulatory Agency (MHRA). For more detail see the "MHRA Licence" section below. In other words, Ozempic has not undergone clinical trials to see if it is effective and safe in treating weight loss, so does not have a product license in the UK for treating obesity. Ozempic has a product licence for controlling Type 2 diabetes, not for weight loss. It contains the active substance Liraglutide which helps aid adults with excess weight ( BMI ≥28 ), who also have weight-related medical problems or those with obesity (BMI ≥30), to lose weight and keep the weight off.

Will Ozempic be available in the future for weight loss?

In fact, Ozempic will never be granted a product licence for weight loss, as it is a brand name. It is the active ingredient in Ozempic called Semaglutide, that is currently undergoing clinical trials for the treatment of weight loss. Semaglutide has now been granted a product licence for weight loss under the brand name of Wegovy and will be a different dosage to that used for diabetic control. We understand from the latest information that Wegovy will become available in the UK during the Spring of 2023. As soon as Wegovy available we will supply it as an alternative to Saxenda.

In the meantime, it is safer to use the licenced product Saxenda.

From only £50 per pen

Medically reviewed by

Superintendent pharmacist Margaret Hudson BSc(Hons) MRPharmS

16 February 2021 and updated 21 September 2022 and updated 21 November 2022

What foods disrupt metabolism?

Five Foods to Cut Back on When It Comes to Metabolism Refined grains. Shutterstock. Refined grains like those found in processed, packaged foods,...

Last updated Dec 22, 2021

What is the oldest age for a tummy tuck?

There is no upper age limit for abdominoplasty (tummy tuck surgery), but there are some considerations that will need to be made regardless of your...

Last updated Mar 30, 2018

Promotion

When will a generic be available for Wegovy?

Wegovy was eligible for patent challenges on Decem. By analyzing the patents and regulatory protections it appears that the earliest date for generic entry will be Decem. ... Summary for WEGOVY. International Patents: 100 DailyMed Link: WEGOVY at DailyMed 11 more rows

drugpatentwatch.com - WEGOVY Drug Patent Profile - DrugPatentWatch

WEGOVY is protected by five US patents and two FDA Regulatory Exclusivities.

Based on analysis by DrugPatentWatch, the earliest date for a generic version of WEGOVY is See Plans and Pricing . This potential generic entry date is based on patent See Plans and Pricing . Generics may enter earlier, or later, based on new patent filings, patent extensions, patent invalidation, early generic licensing, generic entry preferences, and other factors.

Patents protecting WEGOVY

GLP-1 compositions and uses thereof

Patent Number: See Plans and Pricing

Patent Expiration: See Plans and Pricing

Patented Use: METHOD FOR WEIGHT MANAGEMENT

GLP-1 compositions and uses thereof

Patent Number: See Plans and Pricing

Patent Expiration: See Plans and Pricing

Patented Use: METHOD FOR WEIGHT MANAGEMENT

Acylated GLP-1 compounds

Patent Number: See Plans and Pricing

Patent Expiration: See Plans and Pricing

Acylated GLP-1 compounds

Patent Number: See Plans and Pricing

Patent Expiration: See Plans and Pricing

Use of long-acting GLP-1 peptides

Patent Number: See Plans and Pricing

Patent Expiration: See Plans and Pricing

Patented Use: METHOD FOR WEIGHT MANAGEMENT ACCORDING TO A DOSE ESCALATION SCHEDULE

FDA Regulatory Exclusivity protecting WEGOVY

NEW CHEMICAL ENTITY

Exclusivity Expiration: See Plans and Pricing

How many pounds of feces are in the human body?

One product claims that we have anywhere from six to forty pounds of waste, feces and undigested food stuck in our bodies. Another one compares the...

Last updated Dec 7, 2018